Zhou HS - Search Results

1

[Serum α1-acid glycoprotein, imatinib concentration and efficacy in chronic myeloid leukemia patients].

Zhong JS, Meng FY, Xu D, Dai M, Wei YQ, Zhou HS. Zhong JS, et al. Among authors: zhou hs. Zhonghua Yi Xue Za Zhi. 2011 Aug 16;91(30):2120-3. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093988 Chinese.

2

[Monitoring CML28 mRNA levels in patients before and after HSCT by real-time quantitative RT-PCR].

Zhang DH, Dai M, Zhou HS, Wang YY, Zhang L, Zhang L, Wang B, Cao WJ. Zhang DH, et al. Among authors: zhou hs. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):843-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 16277855 Chinese.

3

[Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia].

Yang HP, Dai M, Zhou HS, Huang L, Zhang DH. Yang HP, et al. Among authors: zhou hs. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):677-80. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928298 Chinese.

4

[Construction of HA-1-DC nucleic-acid vaccine and induction of specific cytotoxic T lymphocytes].

Wang YY, Zhang DH, Liu WL, Zhou HS, Zhang L, Dai M, Huang ZQ, Tan H, Xiong P. Wang YY, et al. Among authors: zhou hs. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1178-82. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17204189 Chinese.

5

Imatinib and bortezomib induce the expression and distribution of anaphase-promoting complex adaptor protein Cdh1 in blast crisis of chronic myeloid leukemia.

Wang Q, Zhou HS, Huang KK, Jiang XJ, Wu FQ, Cao R, Yin CX, Liao LB, Zheng ZX, He H, Lin R, Yi ZS, Xu D, Yang M, Meng FY. Wang Q, et al. Among authors: zhou hs. Int J Oncol. 2012 Feb;40(2):418-26. doi: 10.3892/ijo.2011.1233. Epub 2011 Oct 13. Int J Oncol. 2012. PMID: 22002244

6

[Effect of RAD001 or plus LBH589 on the proliferation, apoptosis and drug resistance in chemoresistant acute myeloid leukemic cells].

Jiang XJ, Meng FY, Huang KK, Zhou HS, Wang Q. Jiang XJ, et al. Among authors: zhou hs. Zhonghua Yi Xue Za Zhi. 2011 Aug 30;91(32):2287-92. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22094098 Chinese.

7

[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism].

Jiang XJ, Meng FY, Zhou HS, Wang Q, Wu FQ, Huang KK, Huang M, Wang ZX, Chen WW. Jiang XJ, et al. Among authors: zhou hs. Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):537-42. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22338177 Chinese.

8

Correlation between imatinib trough concentration and efficacy in Chinese chronic myelocytic leukemia patients.

Zhong JS, Meng FY, Xu D, Zhou HS, Dai M. Zhong JS, et al. Among authors: zhou hs. Acta Haematol. 2012;127(4):221-7. doi: 10.1159/000336244. Epub 2012 Mar 30. Acta Haematol. 2012. PMID: 22473087

9

[Study on imatinib trough concentration, efficacy and their relation in chronic myelocytic leukemia].

Zhong JS, Meng FY, Xu D, Zhou HS, Dai M. Zhong JS, et al. Among authors: zhou hs. Zhonghua Xue Ye Xue Za Zhi. 2012 Mar;33(3):177-82. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781602 Chinese.

10

Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways.

Jiang XJ, Huang KK, Yang M, Qiao L, Wang Q, Ye JY, Zhou HS, Yi ZS, Wu FQ, Wang ZX, Zhao QX, Meng FY. Jiang XJ, et al. Among authors: zhou hs. Cancer Lett. 2012 Dec 30;326(2):135-42. doi: 10.1016/j.canlet.2012.07.030. Epub 2012 Aug 1. Cancer Lett. 2012. PMID: 22863538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters